Why the study?
Does serial assessment of systolic time intervals detect early anthracycline-induced cardiotoxicity before echocardiography in patients receiving anthracycline therapy?
Does serial assessment of systolic time intervals detect early anthracycline-induced cardiotoxicity before echocardiography in patients receiving anthracycline therapy?
Serial assessment of systolic time intervals may detect early anthracycline-induced cardiotoxicity before echocardiographic changes occur.
Answers are grounded in this paper and cite their sources.
LSTI monitoring may flag early anthracycline cardiotoxicity before echocardiography; hypothesis-generating in one case and requires prospective validation.
Two cases of anthracycline-induced congestive heart failure are described. Serial assessment of cardiac function during treatment showed early deterioration of the systolic time intervals of the left ventricle (LSTI) before congestive cardiomyopathy could be demonstrated by echocardiography. We recommend that the cardiac function should be assessed regularly during anthracycline therapy by systolic time intervals and echocardiography to reveal early signs of cardiotoxic effect and that anthracycline therapy should be stopped when LSTI is 0.45 or when it has increased more than 50% compared to pretreatment values.
No takes yet. Share an insight, caveat, or question.
Brockmeier et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: